Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Study to Evaluate Induction of HBV Virus Neutralizing Antibodies Using VVX001
Phase 2
- Conditions
- Hepatitis B
- First Posted Date
- 2018-08-10
- Last Posted Date
- 2021-04-06
- Lead Sponsor
- Viravaxx AG
- Target Recruit Count
- 84
- Registration Number
- NCT03625934
- Locations
- 🇦🇹
Medical University of Graz, Graz, Austria
🇦🇹Medical University of Vienna, Vienna, Austria
News
No news found